Results of orbital preservation for advanced malignant maxillary sinus tumors. 2003

Hiroshi Nishino, and Keiichi Ichimura, and Hidetaka Tanaka, and Kazuhiro Ishikawa, and Kouichi Abe, and Yoshiro Fujisawa, and Takeshi Shinozaki
Department of Otolaryngology-Head and Neck Surgery, Jichi Medical School, Kawachi-gun, Tochigi, Japan. hiroshi@jichi.ac.jp

OBJECTIVE The purpose of the study was to examine the oncological and functional outcomes of multimodality therapy for patients with advanced malignant maxillary sinus tumors that invaded the orbit. METHODS Retrospective study. METHODS The medical records of 26 patients with orbital invasion were retrospectively analyzed. The patient group consisted of 16 men and 10 women, with a median age of 58 years. The mean follow-up period was 73 months. The most common disease was squamous cell carcinoma. Seven patients had nodal disease. All patients underwent simultaneous combined therapy consisting of conservative surgery through a sublabial incision, radiotherapy, and regional chemotherapy. Patients with nodal disease were treated with either irradiation or selective neck dissection. RESULTS The 5- and 10-year overall survival rates were 68% and 51%, respectively. The 5- and 10-year local control rates were 66% and 51%, respectively. Overall survival rates and local control rates were significantly worse in patients with disease other than squamous cell carcinoma. Local control rates were significantly worse in patients with orbital apex disease than in patients without orbital apex disease. All 26 patients, despite orbital involvement, retained their orbital contents. Nineteen of these patients demonstrated adequate ocular function. CONCLUSIONS Combined therapy with conservative surgery, radiotherapy, and regional chemotherapy is an effective method for local control and preservation of ocular function. However, performing orbital conservation procedure in patients with disease other than squamous cell carcinoma and with orbital apex disease must be considered carefully.

UI MeSH Term Description Entries
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D008444 Maxillary Sinus Neoplasms Tumors or cancer of the MAXILLARY SINUS. They represent the majority of paranasal neoplasms. Cancer of Maxillary Sinus,Maxillary Sinus Cancer,Neoplasms, Maxillary Sinus,Cancer, Maxillary Sinus,Cancers, Maxillary Sinus,Maxillary Sinus Cancers,Maxillary Sinus Neoplasm,Neoplasm, Maxillary Sinus
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D009918 Orbital Neoplasms Neoplasms of the bony orbit and contents except the eyeball. Neoplasm, Orbital,Neoplasms, Orbital,Orbital Neoplasm
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal

Related Publications

Hiroshi Nishino, and Keiichi Ichimura, and Hidetaka Tanaka, and Kazuhiro Ishikawa, and Kouichi Abe, and Yoshiro Fujisawa, and Takeshi Shinozaki
August 1981, Fogorvosi szemle,
Hiroshi Nishino, and Keiichi Ichimura, and Hidetaka Tanaka, and Kazuhiro Ishikawa, and Kouichi Abe, and Yoshiro Fujisawa, and Takeshi Shinozaki
March 1971, Deutsche Stomatologie,
Hiroshi Nishino, and Keiichi Ichimura, and Hidetaka Tanaka, and Kazuhiro Ishikawa, and Kouichi Abe, and Yoshiro Fujisawa, and Takeshi Shinozaki
January 1977, Revista de chirurgie, oncologie, radiologie, o. r. l., oftalmologie, stomatologie. Seria: Oftalmologie,
Hiroshi Nishino, and Keiichi Ichimura, and Hidetaka Tanaka, and Kazuhiro Ishikawa, and Kouichi Abe, and Yoshiro Fujisawa, and Takeshi Shinozaki
February 1977, The Journal of prosthetic dentistry,
Hiroshi Nishino, and Keiichi Ichimura, and Hidetaka Tanaka, and Kazuhiro Ishikawa, and Kouichi Abe, and Yoshiro Fujisawa, and Takeshi Shinozaki
January 1950, Annali di radiologia diagnostica,
Hiroshi Nishino, and Keiichi Ichimura, and Hidetaka Tanaka, and Kazuhiro Ishikawa, and Kouichi Abe, and Yoshiro Fujisawa, and Takeshi Shinozaki
June 1982, Archives of otolaryngology (Chicago, Ill. : 1960),
Hiroshi Nishino, and Keiichi Ichimura, and Hidetaka Tanaka, and Kazuhiro Ishikawa, and Kouichi Abe, and Yoshiro Fujisawa, and Takeshi Shinozaki
January 1967, Der Krebsarzt,
Hiroshi Nishino, and Keiichi Ichimura, and Hidetaka Tanaka, and Kazuhiro Ishikawa, and Kouichi Abe, and Yoshiro Fujisawa, and Takeshi Shinozaki
February 1976, Otolaryngologic clinics of North America,
Hiroshi Nishino, and Keiichi Ichimura, and Hidetaka Tanaka, and Kazuhiro Ishikawa, and Kouichi Abe, and Yoshiro Fujisawa, and Takeshi Shinozaki
January 1997, Frontiers of radiation therapy and oncology,
Hiroshi Nishino, and Keiichi Ichimura, and Hidetaka Tanaka, and Kazuhiro Ishikawa, and Kouichi Abe, and Yoshiro Fujisawa, and Takeshi Shinozaki
June 2011, Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery,
Copied contents to your clipboard!